United Therapeutics annual debt-to-assets ratio
2009
2010
2013
2014
2015
2019
2021
2022
2023
2024
United Therapeutics Debt-to-Assets Ratio Growth & History (UTHR)
United Therapeutics's debt-to-assets ratio was 0.04 for fiscal 2024.
View full United Therapeutics company overviewUnited Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 0.04 | −0.06 | −58.29% |
| 2023 | 2023-12-31 | 0.10 | −0.03 | −26.20% |
| 2022 | 2022-12-31 | 0.13 | −0.02 | −14.48% |
| 2021 | 2021-12-31 | 0.15 | — | — |
| 2019 | 2019-12-31 | 0.00 | — | — |
| 2015 | 2015-12-31 | 0.00 | −0.06 | −96.31% |
| 2014 | 2014-12-31 | 0.07 | −0.04 | −35.12% |
| 2013 | 2013-12-31 | 0.10 | — | — |
| 2010 | 2010-12-31 | 0.16 | −0.04 | −21.32% |
| 2009 | 2009-12-31 | 0.21 | — | — |
United Therapeutics quarterly debt-to-assets ratio
Q4.09
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q1.19
Q2.19
Q3.19
Q4.19
Q3.22
Q4.24
Q1.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | 0.03 | — | — |
| Q4 2024 | 2024-12-31 | 0.04 | — | — |
| Q3 2022 | 2022-09-30 | 0.00 | — | — |
| Q4 2019 | 2019-12-31 | 0.00 | — | — |
| Q3 2019 | 2019-09-30 | 0.00 | — | — |
| Q2 2019 | 2019-06-30 | 0.00 | — | — |
| Q1 2019 | 2019-03-31 | 0.00 | — | — |
| Q2 2016 | 2016-06-30 | 0.00 | −0.02 | −97.80% |
| Q1 2016 | 2016-03-31 | 0.00 | −0.06 | −95.95% |
| Q4 2015 | 2015-12-31 | 0.00 | −0.06 | −96.31% |
| Q3 2015 | 2015-09-30 | 0.01 | −0.09 | −87.18% |
| Q2 2015 | 2015-06-30 | 0.02 | −0.09 | −83.63% |
| Q1 2015 | 2015-03-31 | 0.06 | −0.04 | −41.20% |
| Q4 2014 | 2014-12-31 | 0.07 | −0.04 | −35.12% |
| Q3 2014 | 2014-09-30 | 0.11 | −0.00 | −1.84% |
| Q2 2014 | 2014-06-30 | 0.11 | −0.00 | −3.97% |
| Q1 2014 | 2014-03-31 | 0.10 | — | — |
| Q4 2013 | 2013-12-31 | 0.10 | — | — |
| Q3 2013 | 2013-09-30 | 0.11 | — | — |
| Q2 2013 | 2013-06-30 | 0.12 | — | — |
| Q3 2011 | 2011-09-30 | 0.15 | −0.03 | −17.54% |
| Q2 2011 | 2011-06-30 | 0.15 | −0.04 | −19.40% |
| Q1 2011 | 2011-03-31 | 0.16 | — | — |
| Q4 2010 | 2010-12-31 | 0.16 | −0.04 | −21.32% |
| Q3 2010 | 2010-09-30 | 0.18 | — | — |
| Q2 2010 | 2010-06-30 | 0.19 | — | — |
| Q4 2009 | 2009-12-31 | 0.21 | — | — |
United Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, United Therapeutics's debt-to-assets ratio increased from 0.00 to 0.04, a change of 0.04. The latest reported quarter, Q1 2025, shows 0.03.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review United Therapeutics source filings ↗